Fremont, CA, United States of America

Maria De Los Angeles Estiarte-Martinez

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Maria De Los Angeles Estiarte-Martinez

Introduction: Maria De Los Angeles Estiarte-Martinez is a prominent inventor based in Fremont, CA, recognized for her significant contributions to the field of pharmaceuticals. With a focus on thrombin inhibitors, her work has led to the development of advanced formulations that promise to enhance the treatment and prevention of thrombin-related diseases.

Latest Patents: Maria holds three patents, with her most recent innovations centered around thrombin inhibitors. The first patent involves "Thrombin inhibitors, formulations, and uses thereof," which details acylated pyrazole-pyridone compounds and their therapeutic potential in treating thrombin-related disorders. These formulations include pharmaceutical compositions such as tablets designed for effective administration. The second patent focuses on "Substituted pyrazole compounds as serine protease inhibitors," which presents multisubstituted aromatic compounds that can inhibit thrombin and kallikrein, offering new methods for treating various medical conditions.

Career Highlights: Maria has made strides in her field through her tenure at notable organizations, including Verseon Corporation and Verseon International Corporation. Her expertise in pharmaceutical innovation is reflected in the patents she has secured, showcasing her dedication to advancing medical science.

Collaborations: Throughout her career, Maria has collaborated with talented professionals such as Kevin Michael Short and David B. Kita. These partnerships have enriched her research projects and contributed to her patent achievements, fostering an environment of innovation and shared knowledge.

Conclusion: Maria De Los Angeles Estiarte-Martinez stands out as a trailblazer in the pharmaceutical industry, driving innovation through her patented work on thrombin inhibitors. Her contributions not only underscore her expertise as an inventor but also hold promise for the future of medical treatment and therapies. Her ongoing commitment to research and collaboration continues to inspire advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…